Interest of Immersive Virtual Reality on Stress During Botulinum Toxin Injections in Spasticity (RVTOX)

Clinical trial NCT05364203 · COMPLETED

Trial details

NCT number: NCT05364203
Sponsor: University Hospital, Clermont-Ferrand
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Central Neurogical Impairment

Start date: 2022-05-10
Primary completion: 2024-12-02
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.